Basic Information
ViroTact, a subsidiary of Detact Diagnostics™ based in the Netherlands, is developing a rapid, affordable, and non-invasive point-of-care test for Covid-19 CoviTact©. This disruptive bacterial detection platform/technology can be applied to the development of applications in healthcare and food.
ViroTact
Netherlands
less than 15 people
January 01, 2020
info@virotact.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios